{"text": ["Performance", "of", "Sanofi\u2019s", "Business", "Segments", "in", "4Q17"], "created_at": "2018-03-01 21:20:02"}
{"text": ["Amgen", "(AMGN)", "Gets", "CHMP", "Nod", "to", "Expand", "EU", "Label", "of", "Neulasta"], "created_at": "2018-03-01 17:12:05"}
{"text": ["Amgen", "(AMGN)", "Gets", "CHMP", "Nod", "to", "Expand", "EU", "Label", "of", "Neulasta"], "created_at": "2018-03-01 17:12:05"}
{"text": ["Aerie's", "(AERI)", "Q4", "Loss", "Wider", "on", "Higher", "Operating", "Expenses"], "created_at": "2018-03-01 16:10:38"}
{"text": ["Aerie's", "(AERI)", "Q4", "Loss", "Wider", "on", "Higher", "Operating", "Expenses"], "created_at": "2018-03-01 16:10:38"}
{"text": ["The", "Swiss", "Stock", "Market", "Extended", "Its", "Losing", "Streak"], "created_at": "2018-03-01 12:24:00"}
{"text": ["The", "Swiss", "Stock", "Market", "Extended", "Its", "Losing", "Streak"], "created_at": "2018-03-01 12:24:00"}
{"text": ["Novartis,", "Pear", "Therapeutics", "To", "Develop", "Digital", "Therapeutics", "For", "Schizophrenia"], "created_at": "2018-03-01 01:41:00"}
{"text": ["Novartis,", "Pear", "Therapeutics", "To", "Develop", "Digital", "Therapeutics", "For", "Schizophrenia"], "created_at": "2018-03-01 01:41:00"}
